Merck
  • 主页
  • 查找结果
  • Inhaled lactonase reduces Pseudomonas aeruginosa quorum sensing and mortality in rat pneumonia.

Inhaled lactonase reduces Pseudomonas aeruginosa quorum sensing and mortality in rat pneumonia.

PloS one (2014-10-29)
Sami Hraiech, Julien Hiblot, John Lafleur, Hubert Lepidi, Laurent Papazian, Jean-Marc Rolain, Didier Raoult, Mikael Elias, Mark W Silby, Janek Bzdrenga, Fabienne Bregeon, Eric Chabriere
摘要

The effectiveness of antibiotic molecules in treating Pseudomonas aeruginosa pneumonia is reduced as a result of the dissemination of bacterial resistance. The existence of bacterial communication systems, such as quorum sensing, has provided new opportunities of treatment. Lactonases efficiently quench acyl-homoserine lactone-based bacterial quorum sensing, implicating these enzymes as potential new anti-Pseudomonas drugs that might be evaluated in pneumonia. The aim of the present study was to evaluate the ability of a lactonase called SsoPox-I to reduce the mortality of a rat P. aeruginosa pneumonia. To assess SsoPox-I-mediated quorum quenching, we first measured the activity of the virulence gene lasB, the synthesis of pyocianin, the proteolytic activity of a bacterial suspension and the formation of biofilm of a PAO1 strain grown in the presence of lactonase. In an acute lethal model of P. aeruginosa pneumonia in rats, we evaluated the effects of an early or deferred intra-tracheal treatment with SsoPox-I on the mortality, lung bacterial count and lung damage. SsoPox-I decreased PAO1 lasB virulence gene activity, pyocianin synthesis, proteolytic activity and biofilm formation. The early use of SsoPox-I reduced the mortality of rats with acute pneumonia from 75% to 20%. Histological lung damage was significantly reduced but the lung bacterial count was not modified by the treatment. A delayed treatment was associated with a non-significant reduction of mortality. These results demonstrate the protective effects of lactonase SsoPox-I in P. aeruginosa pneumonia and open the way for a future therapeutic use.

材料
货号
品牌
产品描述

Sigma-Aldrich
甘油, for molecular biology, ≥99.0%
Sigma-Aldrich
甘油, ≥99.5%
Sigma-Aldrich
磷酸钾二元 二元, ACS reagent, ≥98%
Sigma-Aldrich
硫酸镁, anhydrous, ReagentPlus®, ≥99.5%
Sigma-Aldrich
甘油, ACS reagent, ≥99.5%
Sigma-Aldrich
甘油, ReagentPlus®, ≥99.0% (GC)
Sigma-Aldrich
甘油, BioReagent, suitable for cell culture, suitable for insect cell culture, suitable for electrophoresis, ≥99% (GC)
Supelco
甘油, Pharmaceutical Secondary Standard; Certified Reference Material
Sigma-Aldrich
甘油, meets USP testing specifications
Sigma-Aldrich
甘油 溶液, 83.5-89.5% (T)
Sigma-Aldrich
硫酸镁, anhydrous, reagent grade, ≥97%
Sigma-Aldrich
磷酸钾二元 二元, reagent grade, ≥98.0%
Sigma-Aldrich
硫酸镁 溶液, for molecular biology, 1.00 M±0.04 M
Sigma-Aldrich
L-丙氨酸, ≥98% (TLC)
Sigma-Aldrich
甘油, BioXtra, ≥99% (GC)
Sigma-Aldrich
硫酸镁, BioReagent, suitable for cell culture, suitable for insect cell culture
Sigma-Aldrich
甘油, BioUltra, for molecular biology, anhydrous, ≥99.5% (GC)
Sigma-Aldrich
磷酸钾二元 二元, meets USP testing specifications
Sigma-Aldrich
甘油, FCC, FG
Sigma-Aldrich
硫酸镁, anhydrous, free-flowing, Redi-Dri, ReagentPlus®, ≥99.5%
Sigma-Aldrich
磷酸钾二元 二元, anhydrous, for luminescence, for molecular biology, BioUltra, ≥99.0% (T)
Sigma-Aldrich
硫酸镁, puriss. p.a., drying agent, anhydrous, ≥98.0% (KT), powder (very fine)
USP
甘油, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
磷酸钾 二元 溶液, 1.0 M
Sigma-Aldrich
L-丙氨酸, from non-animal source, meets EP, USP testing specifications, suitable for cell culture, 98.5-101.0%
Sigma-Aldrich
L-丙氨酸, BioUltra, ≥99.5% (NT)
Sigma-Aldrich
硫酸镁, anhydrous, free-flowing, Redi-Dri, reagent grade, ≥97%
Sigma-Aldrich
硫酸镁 溶液, BioUltra, for molecular biology
Supelco
甘油, analytical standard
Sigma-Aldrich
甘油, puriss., meets analytical specification of Ph. Eur., BP, USP, FCC, E422, anhydrous, 99.0-101.0% (alkalimetric)